Rashed Dewan
Finanzdirektor/CFO bei PROFOUND MEDICAL CORP.
Vermögen: 175 015 $ am 31.05.2024
Profil
Rashed Dewan is currently working as the Chief Financial Officer at Profound Medical Corp.
He started this position in 2022.
Previously, he worked as a Controller at Profound Medical, Inc. Mr. Dewan completed his undergraduate degree at the University of Southern California.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
PROFOUND MEDICAL CORP
0,10% | 15.08.2023 | 23 747 ( 0,10% ) | 175 015 $ | 31.05.2024 |
Aktive Positionen von Rashed Dewan
Unternehmen | Position | Beginn |
---|---|---|
PROFOUND MEDICAL CORP. | Finanzdirektor/CFO | 03.03.2022 |
Ehemalige bekannte Positionen von Rashed Dewan
Unternehmen | Position | Ende |
---|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | - |
Ausbildung von Rashed Dewan
University of Southern California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROFOUND MEDICAL CORP. | Health Technology |
Private Unternehmen | 1 |
---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |